Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Oxford Biodyn (OBD)

Price 0.65p on 30-01-2025 at 17:30:01
Change -0.02p -3.08%
Buy 0.70p
Sell 0.60p
Buy / Sell OBD Shares
Last Trade: Sell 450,000.00 at 0.63p
Day's Volume: 2,627,564
Last Close: 0.63p
Open: 0.65p
ISIN: GB00BD5H8572
Day's Range 0.63p - 0.63p
52wk Range: 0.50p - 15.00p
Market Capitalisation: £2m
VWAP: 0.656741p
Shares in Issue: 319m

Recent Trades History Oxford Biodyn (OBD)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 450,000 0.63p Uncrossing Trade
16:35:10 - 30-Jan-25
Buy* 136,234 0.666p Ordinary
16:10:50 - 30-Jan-25
Buy* 40,000 0.666p Ordinary
16:08:12 - 30-Jan-25
Buy* 1,097,448 0.666p Ordinary
14:21:43 - 30-Jan-25
Sell* 106,052 0.635p Ordinary
13:28:45 - 30-Jan-25
Buy* 287 0.6966p Ordinary
12:32:52 - 30-Jan-25
Buy* 28,214 0.6665p Ordinary
11:00:24 - 30-Jan-25
Buy* 125,000 0.667p Ordinary
10:23:53 - 30-Jan-25
Sell* 4,000 0.635p Ordinary
10:23:08 - 30-Jan-25
Buy* 148,276 0.667p Ordinary
10:19:06 - 30-Jan-25

Share Price History for Oxford Biodyn

Time period:
to
Date Open High Low Close Volume

Share News for Oxford Biodyn

IN BRIEF: Oxford BioDynamics raises GBP350,000 via retail offer

17th Jan 2025 21:43

Oxford BioDynamics PLC - Oxford, England-based biotechnology company has two blood testing products on market, the PSE prostate cancer screening test and the CiRT checkpoint inhibitor response test - Raises GBP350,000 via retail share offer at 0.5 pence per share. This is in addition to GBP7.0 million raised by placing and subscription at the same price, announced on Wednesday. Read More

IN BRIEF: Oxford BioDynamics launches GBP6.5 million fund raise

14th Jan 2025 21:20

Oxford BioDynamics PLC - Oxford, England-based biotechnology company has two blood testing products on market, the PSE prostate cancer screening test and the CiRT checkpoint inhibitor response test - Plans to raise GBP6 million via placing at a minimum price of 0.5 pence per share, a subscription and GBP500,000 cornerstone investment by OAK Securities. Further, seeks to raise GBP500,000 via retail offer. The placing will be conducted through an accelerated bookbuilding process. Proceeds will be used as working capital to support the continued commercial development of the EpiSwitch product line through partnerships and collaborations with diagnostic and pharmaceutical companies and direct sales as appropriate. Read More

LONDON MARKET CLOSE: Stocks climb as PM says UK is open for business

14th Oct 2024 17:05

(Alliance News) - London's FTSE 100 closed higher on Monday, although bookmakers suffered, as the UK prime minister played down rumours of a capital gains tax hike and urged investors to back his plans for growth. Read More

Oxford BioDynamics pledges to cut costs amid need to raise extra funds

14th Oct 2024 15:34

(Alliance News) - Oxford BioDynamics PLC on Monday launched a strategic review after warning it would need additional cash resources by early 2025. Read More

Oxford BioDynamics revenue up 49% in first half as test sales rise

18th Jun 2024 16:58

(Alliance News) - Oxford BioDynamics PLC on Tuesday reported strong revenue growth on the back of the increased commercialisation of its EpiSwitch genomics platform. Read More

FTSE 100 Latest
Value8,646.88
Change89.07

Login to your account

Forgot Password?

Not Registered